47 related articles for article (PubMed ID: 38520216)
1. A novel lactylation-related gene signature for effectively distinguishing and predicting the prognosis of ovarian cancer.
Yu L; Jing C; Zhuang S; Ji L; Jiang L
Transl Cancer Res; 2024 May; 13(5):2497-2508. PubMed ID: 38881917
[TBL] [Abstract][Full Text] [Related]
2. Histone modification-linked prognostic model for ovarian cancer reveals LBX2 as a novel growth promoter.
Xiong J; Liang H; Sun X; Gao K
J Cell Mol Med; 2024 Apr; 28(8):e18260. PubMed ID: 38520216
[TBL] [Abstract][Full Text] [Related]
3. Novel immune-related gene signature for risk stratification and prognosis prediction in ovarian cancer.
Fei H; Han X; Wang Y; Li S
J Ovarian Res; 2023 Oct; 16(1):205. PubMed ID: 37858138
[TBL] [Abstract][Full Text] [Related]
4. Crosstalk of RNA Adenosine Modification-Related Subtypes, Establishment of a Prognostic Model, and Immune Infiltration Characteristics in Ovarian Cancer.
Ni X; Chen C; Cui G; Ding W; Liu J
Front Immunol; 2022; 13():932876. PubMed ID: 35837397
[TBL] [Abstract][Full Text] [Related]
5. Glycosylation-related genes mediated prognostic signature contribute to prognostic prediction and treatment options in ovarian cancer: based on bulk and single‑cell RNA sequencing data.
You Y; Yang Q
BMC Cancer; 2024 Feb; 24(1):207. PubMed ID: 38355446
[TBL] [Abstract][Full Text] [Related]
6. N6-Methyladenosine-Related RNA Signature Predicting the Prognosis of Ovarian Cancer.
Jiao J; Jiang L; Luo Y
Recent Pat Anticancer Drug Discov; 2021; 16(3):407-416. PubMed ID: 34137363
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive analysis for the immune related biomarkers of platinum-based chemotherapy in ovarian cancer.
Liu J; Liu Y; Yang C; Liu J; Hao J
Transl Oncol; 2023 Nov; 37():101762. PubMed ID: 37619523
[TBL] [Abstract][Full Text] [Related]
8. MiR-182/Sestrin2 affects the function of asthmatic airway smooth muscle cells by the AMPK/mTOR pathway.
Xiao Y; Zhu H; Lei J; Xie J; Wu K; Gu W; Ma J; Wei D; Shu Z; Zhao L
J Transl Int Med; 2023 Sep; 11(3):282-293. PubMed ID: 37662894
[TBL] [Abstract][Full Text] [Related]
9. Potential of histone deacetylase inhibitors for the therapy of ovarian cancer.
Guo F; Wang H
Front Oncol; 2022; 12():1057186. PubMed ID: 36505774
[TBL] [Abstract][Full Text] [Related]
10. Dysregulation of MiR-144-5p/RNF187 Axis Contributes To the Progression of Colorectal Cancer.
Gao Z; Jiang J; Hou L; Zhang B
J Transl Int Med; 2022 Mar; 10(1):65-75. PubMed ID: 35702180
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of macrophage migration inhibitory factor expression in cancer patients: A systematic review and meta-analysis.
Koh HM; Kim DC
Medicine (Baltimore); 2020 Aug; 99(32):e21575. PubMed ID: 32769903
[TBL] [Abstract][Full Text] [Related]
12. Identification of LBX2 as a novel causal gene of lung adenocarcinoma.
Hu J; Bai Y; Zhang Q; Li M; Yin R; Xu L
Thorac Cancer; 2020 Aug; 11(8):2137-2145. PubMed ID: 32567804
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of LBX2 associated with tumor progression and poor prognosis in colorectal cancer.
Huang X; Yang Y; Yang C; Li H; Cheng H; Zheng Y
Oncol Lett; 2020 Jun; 19(6):3751-3760. PubMed ID: 32382328
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
